Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
2 hedge funds and large institutions have $1.07M invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2018 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 2 → 2 (0)
18.14% less ownership
Funds ownership: 37.49% → 19.35% (-18%)
34% less capital invested
Capital invested by funds: $1.62M → $1.07M (-$549K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 2
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$822K |
| 2 |
Jane Street
New York
|
-$117K |
PILL Hedge Fund Activity: Q3 2018 in Review
2 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q3 2018, worth a combined $1.07M — down 34% from $1.62M a quarter earlier.
Fund positioning in PILL was balanced in Q3 2018: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 2 trimmed.
The largest seller was Susquehanna International Group, cutting an estimated $822K.
- 2 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q3 2018, unchanged from Q2 2018.
- Funds reported $1.07M of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q3 2018, down 34% quarter-over-quarter.
- 0 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q3 2018 and 0 closed out.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q3 2018 was Susquehanna International Group, an estimated $822K sold.
Based on aggregated 13F filings for Q3 2018.